No credit card. No commitment.
5000+ G2 reviews
Bellerophon Therapeutics
Research
Public company
Founded in 2014
Warren, New JerseyBellerophon Therapeutics
ResearchPublic companyFounded in 2014Warren, New Jersey
EmployeesBellerophon Therapeutics' financial review
Bellerophon Therapeutics' Revenue (Yearly)
5.6M
Employees
13
Total Funding
106.7M
Last Funding Round
5M
nasdaq
BLPH
Market cap
1.3M
Bellerophon Therapeutics information
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Bellerophon Therapeutics industries
Research
Biotechnology: pharmaceutical preparations
Health care
Biotechnology research
Bellerophon Therapeutics' financial review
Bellerophon Therapeutics' Revenue (Yearly)
5.6M
Employees
13
Total Funding
106.7M
Last Funding Round
5M
nasdaq
BLPH
Market cap
1.3M
Employee Metrics
Technologies
Notable Alumni
Employees
IT Consultant
Senior Clinical Database Programmer
Director
Sr. Program Manager
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
